Adoption of the new antimalarial drug policy in Tanzania - a cross-sectional study in the community
Open Access
- 6 September 2005
- journal article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 10 (10), 1038-1046
- https://doi.org/10.1111/j.1365-3156.2005.01486.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The process of changing national malaria treatment policy: lessons from country-level studiesHealth Policy and Planning, 2004
- Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine–pyrimethamine as first-line treatmentTransactions of the Royal Society of Tropical Medicine and Hygiene, 2004
- Estimating the needs for artesunate-based combination therapy for malaria case-management in AfricaTrends in Parasitology, 2003
- Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam TanzaniaJournal of Clinical Pharmacy & Therapeutics, 2003
- Disseminating Innovations in Health CarePublished by American Medical Association (AMA) ,2003
- Combination Therapy for MalariaDrugs, 2002
- Using evidence to change antimalarial drug policy in KenyaTropical Medicine & International Health, 2000
- A Household Survey of Source, Availability, and use of Antimalarials in a Rural Area of TanzaniaDrug Information Journal, 1999
- Malaria: Living with drug resistanceParasitology Today, 1993
- Oral rehydration therapy and social marketing in rural KenyaSocial Science & Medicine, 1990